{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:35:55Z","timestamp":1775565355227,"version":"3.50.1"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Radiol Imaging"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003The Head and Neck Imaging Reporting and Data System (NI-RADS) is a standardized reporting format for the categorization of the degree of suspicion for recurrent head and neck malignancies on positron emission tomography\/computed tomography.<\/jats:p><jats:p>\n          Purpose\u2003The purpose of our study was to analyze the efficacy of the NI-RADS rating scale and criteria for contrast-enhanced computed tomography (CECT) alone in predicting the local and regional recurrence of malignancies after chemoradiotherapy.<\/jats:p><jats:p>\n          Material and Methods\u2003CECT of the patients with head and neck cancers receiving radiotherapy and concurrent chemotherapy as a primary treatment was obtained 3 months after the completion of radiotherapy and NI-RADS scoring was done using components of Response Evaluation Criteria in Solid Tumors (RECIST 1.1) criteria. Their management was guided according to the recommendations based on their NI-RADS score.<\/jats:p><jats:p>\n          Results\u2003Thirty patients with squamous cell carcinoma of the neck were included in this study. The positive or negative status of the recurrent disease was based on biopsy results or follow-up protocol as recommended in NI-RADS rating scale. Fifteen patients had path proven recurrence at the primary tumor site. For primary tumor site, disease persistence rates of 4% for NI-RADS 1, 24% for NI-RADS 2, and 80% for NI-RADS 3 scores were seen. Five patients had recurrent lymph nodal disease. For lymph nodal assessment, NI-RADS categories 1, 2, and 3 revealed nodal disease recurrence rates of 5.3, 25, and 66.7%, respectively.<\/jats:p><jats:p>\n          Conclusion\u2003CECT alone may be used to assign the NI-RADS rating scale using RECIST 1.1 criteria to predict the presence or absence of recurrent tumor in patients with neck malignancies.<\/jats:p>","DOI":"10.1055\/s-0042-1754315","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T06:45:55Z","timestamp":1659336355000},"page":"151-158","source":"Crossref","is-referenced-by-count":6,"title":["Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1."],"prefix":"10.1055","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-288X","authenticated-orcid":false,"given":"Ishan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed O.","family":"Reza","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-1817","authenticated-orcid":false,"given":"Ram C.","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-7637","authenticated-orcid":false,"given":"Ashish","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5005\/jp-journals-10001-1132","article-title":"Head and neck cancer burden in India","volume":"4","author":"M R Kulkarni","year":"2013","journal-title":"Int J Head Neck Surg"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semradonc.2003.12.004","article-title":"Target coverage for head and neck cancers treated with IMRT: review of clinical experiences","volume":"14","author":"A S Garden","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/02841860310014886","article-title":"A systematic overview of radiation therapy effects in head and neck cancer","volume":"42","author":"B Zackrisson","year":"2003","journal-title":"Acta Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","article-title":"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice","volume":"293","author":"F Paris","year":"2001","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2214\/AJR.09.4122","article-title":"Parker EE, Hoang JK. The postradiation neck: evaluating response to treatment and recognizing complications","volume":"195","author":"Glastonbury CM1","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"ref6","first-page":"1978","article-title":"RESISTing the need to quantify: putting qualitative FDG-PET\/CT tumor response assessment criteria into daily practice","volume":"40","author":"J G Peacock","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mric.2017.08.004","article-title":"Neck imaging reporting and data system","volume":"26","author":"A H Aiken","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jacr.2015.09.032","article-title":"Implementation of a novel surveillance template for head and neck cancer: neck imaging reporting and data system (NI-RADS)","volume":"13","author":"A H Aiken","year":"2016","journal-title":"J Am Coll Radiol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"E A Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3174\/ajnr.A5157","article-title":"Initial performance of NI-RADS to predict residual or recurrent head and neck squamous cell carcinoma","volume":"38","author":"D A Krieger","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"S 01","key":"ref11","first-page":"E853","article-title":"Optimal timing of first posttreatment FDG PET\/CT in head and neck squamous cell carcinoma","volume":"38","author":"A S Leung","year":"2016","journal-title":"Head Neck"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ctrv.2009.08.007","article-title":"Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up","volume":"35","author":"K Manikantan","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2214\/AJR.09.4110","article-title":"Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know","volume":"195","author":"M Nishino","year":"2010","journal-title":"AJR Am J Roentgenol"}],"container-title":["Indian Journal of Radiology and Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1754315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T08:42:07Z","timestamp":1717749727000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1754315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":13,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,7,30]]},"published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1754315","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0971-3026","1998-3808"],"issn-type":[{"value":"0971-3026","type":"print"},{"value":"1998-3808","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}